A multi-center, open label trial to demonstrate the clinical effectiveness and safety of Gengraf® and Prograf® in Renal Transplant patients
Gengraf-Prograf Trial
General Information
120 patients with de novo renal allograft from about 16 participating sites who meet inclusion/ex
Study Information
Inclusion & Exclusion Criteria
Study Timeline